AU3189299A - Peptide ligands for the erythropoietin receptor - Google Patents

Peptide ligands for the erythropoietin receptor

Info

Publication number
AU3189299A
AU3189299A AU31892/99A AU3189299A AU3189299A AU 3189299 A AU3189299 A AU 3189299A AU 31892/99 A AU31892/99 A AU 31892/99A AU 3189299 A AU3189299 A AU 3189299A AU 3189299 A AU3189299 A AU 3189299A
Authority
AU
Australia
Prior art keywords
peptide ligands
erythropoietin receptor
erythropoietin
receptor
ligands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31892/99A
Inventor
Stephen J. Mcconnell
Dominic G. Spinella
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of AU3189299A publication Critical patent/AU3189299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU31892/99A 1998-03-20 1999-03-17 Peptide ligands for the erythropoietin receptor Abandoned AU3189299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7878498P 1998-03-20 1998-03-20
US60078784 1998-03-20
PCT/US1999/005842 WO1999047151A1 (en) 1998-03-20 1999-03-17 Peptide ligands for the erythropoietin receptor

Publications (1)

Publication Number Publication Date
AU3189299A true AU3189299A (en) 1999-10-11

Family

ID=22146200

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31892/99A Abandoned AU3189299A (en) 1998-03-20 1999-03-17 Peptide ligands for the erythropoietin receptor

Country Status (3)

Country Link
JP (1) JP4361684B2 (en)
AU (1) AU3189299A (en)
WO (1) WO1999047151A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
RS51237B (en) 1998-10-23 2010-12-31 Kirin Amgen Inc. Thrombopoietic compounds
MX2007000216A (en) 2004-07-08 2007-03-15 Amgen Inc Therapeutic peptides.
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
JO3324B1 (en) 2006-04-21 2019-03-13 Amgen Inc Lyophilized Therapeutic Peptibody Formulations
CN110361535A (en) * 2018-04-09 2019-10-22 宁夏医科大学总医院 Detect radioactive probe, the preparation method and application of EPO Receipter

Also Published As

Publication number Publication date
JP2002506828A (en) 2002-03-05
WO1999047151A1 (en) 1999-09-23
JP4361684B2 (en) 2009-11-11

Similar Documents

Publication Publication Date Title
AU1199600A (en) Estrogen receptor ligands
AU2900499A (en) Substituted aminomethylphosphines as ligands for catalysts
AU3615599A (en) Melanocortin receptor ligands
AU1685600A (en) Polypeptides
AU7428498A (en) Diphosphines
AU6868398A (en) Mu-opiate receptor peptides
PL348251A1 (en) Dual function overcap
AUPP418498A0 (en) Improved stud
AU4281999A (en) Peptide
AU5970198A (en) Anti-fas antibodies
GB0127669D0 (en) Polypeptide
AU4930399A (en) Novel Polypeptide
AU5671699A (en) Grp receptor ligands
AU1077200A (en) Novel chimeric polypeptide
GB9815505D0 (en) Polypeptide derivatives
AU3189299A (en) Peptide ligands for the erythropoietin receptor
EP1028947B8 (en) H3 receptor ligands of the phenyl-alkyl-imidazoles type
AU6181498A (en) T1/st2-receptor ligand iii
AU5478599A (en) C3a receptor ligands
AU1184800A (en) Novel polypeptide
AU1552800A (en) Coupled peptides
AU2109200A (en) Polypeptide
AU5886298A (en) Arrangement for tankers
AU5446599A (en) Peptide compounds
AU6637700A (en) Tryptase-like polypeptide ztryp1

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase